FOR IMMEDIATE RELEASE
FHI Clinical Inc. Rebrands as TOTAL TRIALS
Durham – 8 April 2026
FHI Clinical Inc. today announced its official rebrand to TOTAL TRIALS, marking the next phase in the organization’s evolution as a global contract research organization.
TOTAL TRIALS, formerly FHI Clinical Inc., is the new name of the same legal entity and fully replaces FHI Clinical Inc. This rebrand reflects the organization’s expanded capabilities, global reach, and continued commitment to delivering integrated, mission-led clinical trial solutions.
This change represents a full business rebrand and evolution, not the creation of a new company. All operations, services, partnerships, and contractual relationships continue unchanged under the TOTAL TRIALS name.
“TOTAL TRIALS represents who we are today and where we are going,” said Karen Insley, Associate Director – Brand Engagement. “While our name has evolved, our foundation remains unchanged, our people, our expertise, and our commitment to delivering meaningful outcomes in clinical research.”
TOTAL TRIALS will continue to provide end-to-end clinical trial solutions, supporting sponsors across all phases of development with a focus on clarity, speed, and measurable results.
The company’s official website is available at:
👉 https://www.totaltrials.com
About TOTAL TRIALS
TOTAL TRIALS is a global, mission-led contract research organization delivering end-to-end clinical trial solutions. Formerly known as FHI Clinical Inc., the organization continues as the same legal entity under its new name, with no change to its core operations, structure, or service offering.
Media Contact
Karen Insley
+44 7854 643841
[email protected]